(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HYALGAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HYALGAN

ST13

US500000079202959

Class

5, 10

Filing

79202959

Registration

5388830

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

07/09/2026

Trademark type

Combined

Nice classes

5, 10

Filing date

07/19/2016

Registration date

01/30/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/24/2024

Last transaction

07/09/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Abano Terme (PD), IT

Examiner

LEE, JANET H

Current location

Historical data usage

Mark description

The mark consists of the wording "HYALGAN" with a circle in the middle of the bar in the letter "H".

Holders and representatives

Holders

FIDIA FARMACEUTICI S.p.A.
FIDIA FARMACEUTICI S.p.A.

Representatives

Andrew N. Fredbeck FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medical preparations for the treatment of arthrosis and osteoarthritis; pharmaceutical and medical preparations for the treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical and medical preparations for the treatment of rheumatological diseases; analgesic preparations; pharmaceutical and medical preparations for the treatment of diseases of the muscular and skeletal system; veterinary preparations for the treatment of the joints and for the treatment of traumatic and degenerative joint pathologies and of diseases of the muscular and skeletal system; Syringes sold filled with the aforementioned preparations

Class 10

Surgical apparatus and devices; syringescannulasmedical and surgical instruments for administering pharmaceutical and veterinary preparations; medicalsurgicalveterinary devices and apparatus for the treatment of traumatic and degenerative joint pathologies and for orthopedic surgery

Publications

History of USPTO decisions and trademark events.

36 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/09/2026

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/07/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

10/01/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

10/01/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/24/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

09/24/2024

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

09/24/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/23/2024

ES71

TEAS SECTION 71 RECEIVED

01/22/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/30/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/04/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/06/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/30/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/15/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/03/2018

FIMP

FINAL DISPOSITION PROCESSED

05/03/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/30/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

01/30/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/18/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/14/2017

PUBO

PUBLISHED FOR OPPOSITION

11/14/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/25/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/06/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/25/2017

ALIE

ASSIGNED TO LIE

09/20/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/14/2017

RFNT

REFUSAL PROCESSED BY IB

04/02/2017

MAFR

APPLICATION FILING RECEIPT MAILED

03/17/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/15/2017

RFRR

REFUSAL PROCESSED BY MPU

03/15/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2017

CNRT

NON-FINAL ACTION WRITTEN

03/13/2017

DOCK

ASSIGNED TO EXAMINER

03/13/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/13/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/09/2017

Continuous trademark protection

Get notified about every new filing that threatens HYALGAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.